Adalimumab (Humira®) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8þ, CD14þ, and CD19þ leucocyte subsets in rheumatoid arthritis

Marlene Andersen, Michael Kruse Olesen, I. Nagaev, O. Nagaeva, J. Wikberg, L. Mincheva-Nilsson, Grethe Neumann Andersen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume43
Issue numberSupplement 127
Pages (from-to)25-26
ISSN0300-9742
Publication statusPublished - 2014
Event35th Scandinavian Congress of Rheumatology: 2014 - Stockholm, Sweden
Duration: 20 Sep 201423 Sep 2014
Conference number: 35

Conference

Conference35th Scandinavian Congress of Rheumatology
Number35
CountrySweden
CityStockholm
Period20/09/201423/09/2014

Cite this

Andersen, Marlene ; Olesen, Michael Kruse ; Nagaev, I. ; Nagaeva, O. ; Wikberg, J. ; Mincheva-Nilsson, L. ; Andersen, Grethe Neumann. / Adalimumab (Humira®) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8þ, CD14þ, and CD19þ leucocyte subsets in rheumatoid arthritis. In: Scandinavian Journal of Rheumatology. 2014 ; Vol. 43, No. Supplement 127. pp. 25-26.
@article{589900db1fe94172818980ffebbbdf7f,
title = "Adalimumab (Humira{\circledR}) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8{\th}, CD14{\th}, and CD19{\th} leucocyte subsets in rheumatoid arthritis",
author = "Marlene Andersen and Olesen, {Michael Kruse} and I. Nagaev and O. Nagaeva and J. Wikberg and L. Mincheva-Nilsson and Andersen, {Grethe Neumann}",
year = "2014",
language = "English",
volume = "43",
pages = "25--26",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Taylor & Francis",
number = "Supplement 127",

}

Adalimumab (Humira®) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8þ, CD14þ, and CD19þ leucocyte subsets in rheumatoid arthritis. / Andersen, Marlene; Olesen, Michael Kruse; Nagaev, I.; Nagaeva, O.; Wikberg, J.; Mincheva-Nilsson, L.; Andersen, Grethe Neumann.

In: Scandinavian Journal of Rheumatology, Vol. 43, No. Supplement 127, 2014, p. 25-26.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - Adalimumab (Humira®) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8þ, CD14þ, and CD19þ leucocyte subsets in rheumatoid arthritis

AU - Andersen, Marlene

AU - Olesen, Michael Kruse

AU - Nagaev, I.

AU - Nagaeva, O.

AU - Wikberg, J.

AU - Mincheva-Nilsson, L.

AU - Andersen, Grethe Neumann

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

VL - 43

SP - 25

EP - 26

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - Supplement 127

ER -